株式会社極東書店トップ ＞ 商品一覧 ＞ The Interplay of Global Standards and EU Pharmaceutical Regulation : The International Council for Harmonisation.
商品詳細
The Interplay of Global Standards and EU Pharmaceutical Regulation : The International Council for Harmonisation.
・ISBN 978-1-5099-4299-2 hard GB£ 95.00
￥30,096.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
電子版あり 大学・学術機関向け電子ブック（eBook）ISBN 978-1-5099-4302-9
| 著者・編者 | Röttger-Wirtz, Sabrina, |
|---|---|
| シリーズ | Hart Studies in Law and Health |
| 出版社 | (Hart, UK) |
| 出版年月 | 2021.09 |
| ページ数 | 288 pp. |
| 言語 | ENG |
| ニュース番号 | ＜663-668 663-L1772＞ |
解説
This book analyses the implementation of global pharmaceutical impact standards in the European risk regulation framework for pharmaceuticals and questions its legitimacy.
Global standards increasingly shape the risk regulation law and policy in the European Union and the area of pharmaceuticals is no exception to this tendency. As this book shows, global pharmaceutical standards set by the International Council for Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH), after they are adopted through the European Medicines Agency (EMA), are an important feature of the regulatory framework for pharmaceuticals in the EU.
In addition to analysing the influence of these global standards in the EU legal and policy framework, the book questions the legitimacy of the Union's reliance on global standards in terms of core administrative law principles of participation, transparency and independence of expertise. It also critically examines the accountability of the European Commission and the European Medicines Agency as participants in the global standard-setting and main implementation gateway of the global pharmaceutical standards into the European Union.